Covance, Inc. (NYSE:CVD)

CAPS Rating: 4 out of 5

A drug development services company providing a range of early stage and late stage product development services on a worldwide basis primarily to the pharmaceutical, biotechnology and medical device industries.

Recs

0
Player Avatar HealthcareGuy (98.87) Submitted: 4/1/2011 4:00:57 PM : Outperform Start Price: $57.40 CVD Score: -18.18

Inflection pt in CRO activity

Featured Broker Partners


Advertisement